JSC "Grindeks" informs, that Supervisory Council reappointed Jānis Romanovskis as the Chairman of the Board and Lipmans Zeligmans, Director of Final Dosage Forms Manufacturing, as a Board Member. They have been reappointed for the next three years.

The reason for the reappointment - expiry of terms of office on 2 January 2010.

Vadims Rabša, Finance and Administrative Director, continues to work as a Board Member. His terms of office will expire on 13 October 2011.
 

Supervisory Council of “Grindeks” – Kirovs Lipmans, Chairman of the Council (ownership interests – 33.29%), Vitālijs Gavrilovs, Deputy Chairman of the Council (ownership interests – 11,30%), Anna Lipmane, Member of the Council (ownership interests – 16,69%), Uldis Osis, Member of the Council and Jānis Naglis, Member of the Council.

About “Grindeks”
“Grindeks” is the leading pharmaceutical company in the Baltic States. The main directions of its operation are research, development, manufacturing and sales of original products, as well as generics and active pharmaceutical ingredients. “Grindeks” concern consists of four subsidiary companies in Latvia, Estonia and Russia; as well as representatives and representative offices in 14 countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, as well as Japan and USA. The shares of JSC “Grindeks” are listed in the Official List of “NASDAQ OMX Riga”.

Further information:

Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
E-mail: laila.klavina@grindeks.lv
Phones: +371 67083370, +371 29256012